ZFP82

Across TCGA pan-cancer cohorts, ZFP82 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of ZFP82’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where ZFP82 RNA is repressed in tumor relative to normal tissue. In most cancer types ZFP82 is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

THCA, KIRC, and KICH are the cancer types where ZFP82 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ZFP82 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	II,III,IV	−0.780	<.001	11	view →
KIRC	Female	All	+0.430	<.001	10	view →
KICH	Male	IV	−1.096	<.001	7	view →
COAD	Male	All	−0.448	<.001	7	view →
LIHC	Female	All	+0.415	<.001	5	view →
UCEC	All	All	−0.826	<.001	4	view →
LUAD	All	All	+0.234	.007	3	view →
CHOL	All	All	+0.665	.006	2	view →
KIRP	All	IV	+0.639	.038	2	view →
BLCA	Female	IV	+1.073	.011	1	view →
READ	All	All	−0.575	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

ZFP82–THCA

Open the THCA breakdown →